DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Wednesday reported a loss of $4.9 million in its first quarter.
The Dublin-based company said it had a loss of 5 cents per share.
The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The specialty pharmaceutical company posted revenue of $52.5 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $50.7 million.
Avadel shares have fallen 18% since the beginning of the year. The stock has dropped 54% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
